Evidence map›Paper›PMID 30919344›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2019

A Brief History of the β-Arrestins.

Marc G Caron, Lawrence S Barak

Abstract readHistorical ArticleReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marc G CaronDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA. marc.caron@duke.edu.
Lawrence S BarakDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA. Lawrence.Barak@duke.edu.

Funding

Screening CoreU19MH082441 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, MARC G., WETSEL, WILLIAM C · 2007 to 2016
$15.2M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Science PlanP30DA029925 · NIDA · DUKE UNIVERSITY · PI CARON, MARC G. · 2010 to 2018
$6.2M
A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple OncogenesR33CA191198 · NCI · DUKE UNIVERSITY · PI CARON, MARC G. · 2015 to 2017
$1.2M
Howard Hughes Medical InstituteNCI NIH HHS R33 CA191198NIDA NIH HHS P30 DA029925NIMH NIH HHS R37 MH073853NIMH NIH HHS U19 MH082441
6 · The paper itself

Abstract

Arrestins have now been implicated in the actions of virtually every G protein-coupled receptor (GPCR) for which they have been examined. Originally discovered for their role in the turnoff of visual perception, their newly discovered pleotropic functions in the cellular and physiological actions of GPCRs not only illuminate new mechanisms of signal transduction but also offer new avenues for therapeutic utility. Below, in this introductory chapter, we provide a short historical description and synopsis of how arrestins conceptually became associated with the function of GPCRs.

Indexed as

Animalsbeta-ArrestinsHistory, 20th CenturyHumansbeta-ArrestinsDesensitizationEndocytosisGPCRGPCR kinasesSignaling selectivity/biasTherapeuticsβ-Arrestins

Identifiers

PMID30919344
PMCPMC6736645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.